Abstract
The analysis of nanoparticles' biocompatibility and immunogenicity is mostly performed under a healthy condition. However, more clinically relevant evaluation conducted under pathological condition is less known. Here, the immunogenicity and bio-nano interactions of porous silicon nanoparticles (PSi NPs) are evaluated in an acute liver inflammation mice model. Interestingly, a new mechanism in which PSi NPs can remit the hepatocellular damage and inflammation activation in a surface dependent manner through protein corona formation, which perturbs the inflammation by capturing the pro-inflammatory signaling proteins that are inordinately excreted or exposed under pathological condition, is found. This signal sequestration further attenuates the nuclear factor kappa B pathway activation and cytokines production from macrophages. Hence, the study proposes a potential mechanism for elucidating the altered immunogenicity of nanomaterials under pathological conditions, which might further offer insights to establish harmonized standards for assessing the biosafety of biomaterials in a disease-specific or personalized manner.
Original language | English |
---|---|
Article number | 2001129 |
Journal | Advanced Science |
Volume | 7 |
Issue number | 15 |
Number of pages | 12 |
ISSN | 2198-3844 |
DOIs | |
Publication status | Published - 7 Aug 2020 |
MoE publication type | A1 Journal article-refereed |
Fields of Science
- BIOCOMPATIBILITY
- BLOOD
- FIBRILLATION
- IRON-OXIDE NANOPARTICLES
- MECHANISMS
- OXIDATION
- PROTEIN CORONA
- R-language
- RELEASE
- SURFACE
- TUMOR-GROWTH
- acute liver inflammation
- immunogenicity
- porous silicon
- protein corona
- 116 Chemical sciences
- 317 Pharmacy